These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34782275)

  • 41. Allergen immunotherapy now and in the future.
    Nelson HS
    Allergy Asthma Proc; 2016 Jul; 37(4):268-72. PubMed ID: 27401313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of patients for sublingual versus subcutaneous immunotherapy.
    Larenas Linnemann DE; Blaiss MS
    Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status of sublingual immunotherapy for allergic rhinitis in Japan.
    Masuyama K; Matsuoka T; Kamijo A
    Allergol Int; 2018 Jul; 67(3):320-325. PubMed ID: 29805085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modified allergens and their potential to treat allergic disease.
    Jongejan L; van Ree R
    Curr Allergy Asthma Rep; 2014 Dec; 14(12):478. PubMed ID: 25269402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience.
    Jensen-Jarolim E; Roth-Walter F; Jordakieva G; Pali-Schöll I
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1780-1789. PubMed ID: 33753052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of tolerance via the sublingual route: mechanisms and applications.
    Moingeon P; Mascarell L
    Clin Dev Immunol; 2012; 2012():623474. PubMed ID: 22110534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
    Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
    Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy.
    Tanaka Y; Fukumoto S; Sugawara S
    J Oral Biosci; 2019 Jun; 61(2):73-77. PubMed ID: 31109864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United States.
    Epstein TG; Calabria C; Cox LS; Dreborg S
    J Allergy Clin Immunol Pract; 2017; 5(1):34-40.e2. PubMed ID: 27815065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Food allergen-specific sublingual immunotherapy modulates peripheral T cell responses of dogs with adverse food reactions.
    Maina E; Devriendt B; Cox E
    Vet Immunol Immunopathol; 2019 Jun; 212():38-42. PubMed ID: 31213250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological mechanisms of sublingual allergen-specific immunotherapy.
    Novak N; Bieber T; Allam JP
    Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial effects of Galectin-9 on allergen-specific sublingual immunotherapy in a Dermatophagoides farinae-induced mouse model of chronic asthma.
    Ikeda M; Katoh S; Shimizu H; Hasegawa A; Ohashi-Doi K; Oka M
    Allergol Int; 2017 Jul; 66(3):432-439. PubMed ID: 27876361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sublingual immunotherapy: recent advances.
    Compalati E; Braido F; Walter Canonica G
    Allergol Int; 2013 Dec; 62(4):415-23. PubMed ID: 24280671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.
    Palomares O; Akdis M; Martín-Fontecha M; Akdis CA
    Immunol Rev; 2017 Jul; 278(1):219-236. PubMed ID: 28658547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of IL-35 in sublingual allergen immunotherapy.
    Shamji MH; Layhadi JA; Achkova D; Kouser L; Perera-Webb A; Couto-Francisco NC; Parkin RV; Matsuoka T; Scadding G; Ashton-Rickardt PG; Durham SR
    J Allergy Clin Immunol; 2019 Mar; 143(3):1131-1142.e4. PubMed ID: 30053528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.
    Incorvaia C; Ciprandi G; Nizi MC; Makri E; Ridolo E
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):245-257. PubMed ID: 32372588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-delivery of allergen epitope fragments and R848 inhibits food allergy by inducing tolerogenic dendritic cells and regulatory T cells.
    Hong J; Xiao X; Gao Q; Li S; Jiang B; Sun X; Ran P; Yang P
    Int J Nanomedicine; 2019; 14():7053-7064. PubMed ID: 31564865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allergen-specific immunotherapy.
    Nelson HS; Norman PS
    Chem Immunol Allergy; 2014; 100():333-8. PubMed ID: 24925414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.